AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (November 15, 2005). doi:10.1152/ajpendo.00376.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/4/E739    most recent
00376.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lundahl, B.
Right arrow Articles by Karpe, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lundahl, B.
Right arrow Articles by Karpe, F.
Submitted on August 12, 2005
Accepted on November 14, 2005

The microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles

Bjorn Lundahl1, Camilla Skoglund-Andersson1, Muriel Caslake2, Dorothy Bedford2, Philip Stewart2, Anders Hamsten1, Christopher J Packard2, and Fredrik Karpe3*

1 Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institute, Stockholm, Sweden
2 Department of Pathological Biochemistry, University of Glasgow, Glasgow, Scotland, United Kingdom
3 Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institute, Stockholm, Sweden; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom

* To whom correspondence should be addressed. E-mail: fredrik.karpe{at}ocdem.ox.ac.uk.

The microsomal triglyceride transfer protein (MTP) is essential for the synthesis and secretion of apoB-containing lipoproteins. We investigated the role the MTP -493G/T gene polymorphism in determining the apoB-100 secretion pattern and LDL heterogeneity in healthy human subjects. Groups of carriers of the T and the G variant (n=6, respectively) were recruited from a cohort of healthy, 50-year-old men. Kinetic studies were performed by endogenous d3-Leucine labelling of apoB and subsequent quantification of the stable isotope incorporation. ApoB production rates, metabolic conversions and eliminations were calculated by multicompartmental modelling (SAAM-II). LDL subfraction distribution was analyzed in the entire cohort (n=377). Carriers of the MTP-493T allele had lower plasma LDL apoB and lower concentration of large LDL particles (LDL-I: 136±57 (TT) vs. 175±55 (GG) mg/L, p<0.01). Kinetic modelling suggested that MTP-493T homozygotes had 60% lower direct production rate of intermediate density lipoprotein (IDL)+ LDL compared with homozygotes for the G allele (p<0.05). No differences were seen in production rates of large and small VLDL, nor were there any differences in metabolic conversion or elimination rates of apoB between the genotype groups. This study shows that a polymorphism in the MTP gene affects the spectrum of endogenous apoB-containing lipoprotein particles produced in humans. Reduced direct production of LDL+IDL appears to be related to lower plasma concentrations of large LDL particles.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
F. Basso, L. A. Freeman, C. Ko, C. Joyce, M. J. Amar, R. D. Shamburek, T. Tansey, F. Thomas, J. Wu, B. Paigen, et al.
Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited
J. Lipid Res., January 1, 2007; 48(1): 114 - 126.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.